Belgium · Investor

Biotech Fund Flanders

Last cheque observed May 2020. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series BSeries CSeries DBiotechnologyTherapeutics

Cheques on record
0%of best year0cheques in 12 months, 7 on record
Since the last cheque2342days00hrs00min00sec
Median round$6.6MRounds led0 of 7Exits2 from the portfolioMostly inBelgium, 86%
Pitch Biotech Fund Flanders

Biotech Fund Flanders highlights

  1. 01

    7 rounds on record

  2. 02

    Mostly Series B and Series C: 71% of its rounds

  3. 03

    2 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyTherapeutics
Based in
Belgium
Cold pitches
Not stated

The record

Every round we can evidence, newest first7 appearances

  1. 2020

    1 round

  2. May
    ViroVet NVSeries B · BE · Capricorn Partners$6.6MWith 7 others
  3. 2012

    1 round

  4. Jan
    PronotaSeries C · BE · pronota.com$4.8MWith 6 others
  5. 2009

    1 round

  6. Jun
    PronotaSeries B · BE · pronota.com$7.4MWith 6 others
  7. 2007

    2 rounds

  8. Jul
    DiatosSeries D · FR$13MWith 2 others
  9. Feb
    ActoGeniXVenture · BE$26MWith 5 others
  10. 2006

    1 round

  11. Aug
    AblynxSeries C · BE$50MWith 7 others
  12. 2004

    1 round

  13. Apr
    AblynxSeries B · BE$30MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

ActoGeniXBought by Intrexon Corporation$60MFeb 2015
AblynxListedUndisclosedNov 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Biotech Fund Flanders. A count of rooms they were both in, not a relationship either has claimed.

GimvPrivate equity5rounds togetherEQT life sciencePrivate equity3rounds togetherAbingworthVC firm2rounds togetherAlta PartnersVC firm2rounds togetherBaekeland FundsVC firm2rounds togetherGilde HealthcarePrivate equity2rounds togetherJohnson & Johnson Development Corporation (JJDC)VC firm2rounds togetherKBC Private EquityPrivate equity2rounds togetherSofinnova PartnersVC firm2rounds togetherVIBVC firm2rounds together

Quick answers about Biotech Fund Flanders

What does Biotech Fund Flanders invest in?

Biotech Fund Flanders invests most often at Series B and Series C (71% of the rounds on record), in sectors such as Biotechnology and Therapeutics.

How active is Biotech Fund Flanders?

7 investments on record, 0 of them in the last 12 months. The most recent was in May 2020.

What has Biotech Fund Flanders invested in recently?

Its most recent investments on record: ViroVet NV (Series B, May 2020).

How big are Biotech Fund Flanders's cheques?

The median round it joins is $6.6M.

Does Biotech Fund Flanders lead rounds?

Rarely, if at all: none of its 7 investments on record names it as the lead.

Where does Biotech Fund Flanders invest?

Most of the companies it backs are in Belgium (86%) and France (14%).

Is Biotech Fund Flanders investing now?

No investments in the last 12 months; the latest was in May 2020.

Who does Biotech Fund Flanders invest alongside?

Most often Gimv (5 rounds together), EQT life science (3 rounds together) and Abingworth (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it